What Happened?

Shares of dialysis provider DaVita Inc. (NYSE:DVA) fell 14% in the morning session after the company reported weak fourth-quarter results: DaVita narrowly exceeded analysts' revenue expectations but fell short on full-year EPS guidance. A key challenge remains patient volume, as center closures could continue to pressure growth. Overall, this quarter could have been better.

The shares closed the day at $157.41, down 11.1% from previous close.

The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy DaVita? Access our full analysis report here, it’s free .

What The Market Is Telling Us

DaVita’s shares are not very volatile and have only had 3 moves greater than 5% over the last year. Moves this big are rare for DaVita and indicate this news significantly impacted the market’s perception of the business.

DaVita is up 5.1% since the beginning of the year, but at $157.42 per share, it is still trading 11.2% below its 52-week high of $177.35 from February 2025. Investors who bought $1,000 worth of DaVita’s shares 5 years ago would now be looking at an investment worth $1,831.

Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. .